Alzeca Biosciences
Latest round
- Series A
Last raised
- Aug 2017
Total raised
- $11M
Investors
- 1
About Alzeca Biosciences
Established in 2012 and based in Texas, US, Alzeca Biosciences, Inc. develops MRI-based imaging technologies to detect early stages of neurodegenerative diseases. As of 2024, the company is headed by its CEO Carlo Medici. The company offers imaging technologies that leverage MRI and CT scanning technologies which enables the early detection of Alzheimer’s Disease pathology. The firm technology helps to improve patient selection and monitoring of Alzheimer’s patients in clinical trials, and differential diagnosis of patients with MCI (Mild Cognitive Impairment).
Who invested in Alzeca Biosciences
1 investor across 1 round
See all investors in Alzeca Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 17, 2017
Amount
$11M
Investors
Questions about Alzeca Biosciences
Who invested in Alzeca Biosciences?
Alzeca Biosciences has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alzeca Biosciences raised?
Alzeca Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Alzeca Biosciences last raise money?
Alzeca Biosciences's most recent round on record is a Series A, in Aug 2017.
What does Alzeca Biosciences do?
Established in 2012 and based in Texas, US, Alzeca Biosciences, Inc.
Where is Alzeca Biosciences headquartered?
Alzeca Biosciences is headquartered in Houston, US.
Which VCs invest in companies like Alzeca Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Alzeca Biosciences's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Alzeca Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.